1Ambrosy AP, Fonarow GC, Butler J, et al. The Global Health and Econo- mic Burden of Hospitalizations for Heart Failure : Lessons Learned From Hospitalized Heart Failure Registries[J]. J Am Coll Cardiol, 2014,63 ( 12 ) : 1123-1133. 被引量：1
4Gu J, Noe A, Chandra P, et al. Pharmacokinetics and pharmacodynamics of LCZ696,a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi) [J]. J Clin Pharmacol, 2010,50 (4) : 401-414. 被引量：1
5Voors AA, Dorhout B, van der Meer P. The potential role of valsartan+ AHU377 (LCZ696) in the treatment of heart failure[J]. Expert Opin In- vestig Drugs ,2013,22(8) : 1041-1047. 被引量：1
6McMurray JJ, Packer M, Desai AS, et al. Dual angiotensin receptor and neprily-sin inhibition as an alternative to angio-tensin-converting enzyme inhibition in patients with chronic systolic heart failure : rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARA- DIGM-HF)[J]. Eur J Heart Fail, 2013,15 (3) : 1062-1073. 被引量：1
7王吉耀主编..内科学[M].北京:人民卫生出版社,2010:1286.
8de Bold A J, Borenstein HB,Veress AT, et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats[J]. Life Sci, 1981,28 ( 1 ) : 89-94. 被引量：1
9P. Perrone Filardi(ed.). ACEi and ARBS in Hypertension and Heart Failure. Current Cardiovascular Therapy, 2015,5. 被引量：1
10Brandt RR, Redfield MM, Aarhus LL, et al. Clearance receptor-mediated control of atrial natriuretic factor in experimental congestive heart failure[J]. Am J Physiol, 1994,266 (3 Pt 2) : R936-R943. 被引量：1
6Lopez AD.Assessing the burden of mortaIity from cardiovascuIar diS-eases[J]WorId Health Star Q,1993(02):91-96. 被引量：1
7World health organization.Cardiovascular disease:prevention and control. 被引量：1
8Mendez GF;Cowie MR.The epidemiological features of heart failure in developing countries:a review of the literature[J]International Journal of Cardiology,2001(2-3):213-219. 被引量：1
9Dickstein K;Cohen-Solal A;Filippatos G.ESC Guidelines for the diagnosis and treatment of acute andchronic heart failure 2008 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)</a>[J].European Journal of Heart Failure,2008(10):933-989. 被引量：1
10Roger VL;Weston SA;Redfield MA.Trends in heart failure incidence and survival in a community-based population[J]Journal of the American Medical Association,2004(03):344-350. 被引量：1
